(Q57195301)

English

Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity

scientific article published on 10 August 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anders Woetmann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Anders Elm Pedersen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Kirstine Lavrsen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Niels Ødum

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Henrik Clausen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Caroline B Madsen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Morten G Rasch

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

10 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Glycoconjugate Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

227-236

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Cell surface-associated mucins in signal transduction

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

MUC1 and the immunobiology of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Role of E box and initiator region in the expression of the rat follicle-stimulating hormone receptor

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Mucin-type O-glycosylation and its potential use in drug and vaccine development

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Signal transduction through glyco(sphingo)lipids. Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Seromic profiling of colorectal cancer patients with novel glycopeptide microarray

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Random Glycopeptide Bead Libraries for Seromic Biomarker Discovery

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. Identification and separation of two distinct transferase activities.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Molecular cloning and genomic analysis of mouse GalNAc alpha2, 6-sialyltransferase (ST6GalNAc I)

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

MUC1 immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

O-linked glycosylation in the mammary gland: changes that occur during malignancy.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Interleukin-21 enhances NK cell activation in response to antibody-coated targets

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"?

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

PankoMab: a potent new generation anti-tumour MUC1 antibody

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

The genetic and evolutionary balances in human NK cell receptor diversity

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15

1 reference

https://api.crossref.org/works/10.1007%2FS10719-012-9437-7

21 January 2018

Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification and cDNA Cloning of a Human UDP-N-acetyl-α- D-galactosamine:polypeptide N-Acetylgalactosaminyltransferase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T and Tn, general carcinoma autoantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22878593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10719-012-9437-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22878593%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57195301&oldid=2242893344"